Por favor, use este identificador para citar o enlazar este ítem:
http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2230| Título : | Current consensus guidelines for treatment of neurocysticercosis |
| Creador: | García, HH |
| Nivel de acceso: | Open access |
| Palabras clave : | Antiparasitarios - uso terapéutico Neurocisticercosis - diagnóstico Neurocisticercosis - terapia Guías de práctica como asunto Antiparasitic Agents - therapeutic use Neurocysticercosis - diagnosis Neurocysticercosis - therapy Practice Guidelines as Topic antiinflammatory agent; antiparasitic agent; antiparasitic agent; calcification; cyst; human; neurocysticercosis; review; seizure; animal; neurocysticercosis; practice guideline; Animals; Antiparasitic Agents; Humans; Neurocysticercosis; Practice Guidelines |
| Descripción : | Taenia solium neurocysticercosis is a common cause of epileptic seizures and other neurological morbidity in most developing countries. It is also an increasingly common diagnosis in industrialized countries because of immigration from areas where it is endemic. Its clinical manifestations are highly variable and depend on the number, stage, and size of the lesions and the host's immune response. In part due to this variability, major discrepancies exist in the treatment of neurocysticercosis. A panel of experts in taeniasis/cysticercosis discussed the evidence on treatment of neurocysticercosis for each clinical presentation, and we present the panel's consensus and areas of disagreement. Overall, four general recommendations were made: (i) individualize therapeutic decisions, including whether to use antiparasitic drugs, based on the number, location, and viability of the parasites within the nervous system; (ii) actively manage growing cysticerci either with antiparasitic drugs or surgical excision; (iii) prioritize the management of intracranial hypertension secondary to neurocysticercosis before considering any other form of therapy; and (iv) manage seizures as done for seizures due to other causes of secondary seizures (remote symptomatic seizures) because they are due to an organic focus that has been present for a long time. |
| Colaborador(es) u otros Autores: | Evans CA Nash TE Takayanagui OM White AC Jr Botero D Rajshekhar V Tsang VC Schantz PM Allan JC Flisser A Correa D Sarti E Friedland JS Martinez SM Gonzalez AE Gilman RH Del Brutto OH. |
| Fecha de publicación : | 2002 |
| Tipo de publicación: | Revisión |
| Formato: | |
| Identificador del Recurso : | 10.1128/CMR.15.4.747-756.2002 |
| Fuente: | Clinical Microbiology Reviews 15(4):747 - 756 |
| URI : | http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2230 |
| Idioma: | eng |
| Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.